Infliximab and Ulcerative Colitis
4.9 (169) · $ 10.99 · In stock
Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.
ARCH Study: Higher Doses of Infliximab in Acute Severe Ulcerative Colitis
Pharmaceutics, Free Full-Text
PDF) Review Article: Acute Severe Ulcerative Colitis, An Update on Optimal Medical Management
PDF) Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
Ulcerative Colitis (Pfizer) - Ulcerative Colitis
GEN0422_007b_13789_.jpg
Ulcerative colitis - The Lancet
Frontiers Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD - Mayo Clinic
